Results 201 to 210 of about 435,005 (359)

The effects of early exercise on cardiovascular biomarkers in patients with congestive heart failure

open access: yesESC Heart Failure, Volume 12, Issue 4, Page 2985-2992, August 2025.
Abstract Background Exercise training improves functional outcomes in chronic heart failure (HF), but the effects of early in‐hospital physical activity on cardiovascular biomarkers and prognosis in acute congestive heart failure (AHF) patients remain unclear.
Yanxiang Sun   +6 more
wiley   +1 more source

mTOR in cerebrovascular disease

open access: yesAging, 2019
Candice E. Van Skike   +2 more
openaire   +3 more sources

Nutritional risk, frailty and functional status in elderly heart failure patients

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Heart failure (HF) in elderly patients is frequently associated with frailty, malnutrition and reduced functional status. This study assessed the associations between nutritional risk, functional capacity, frailty and length of hospital stay (LOHS) in elderly patients hospitalized with HF.
Magdalena Lisiak   +5 more
wiley   +1 more source

White matter tract correlations with spoken language in cerebrovascular disease. [PDF]

open access: yesBrain Commun
Broberg DN   +22 more
europepmc   +1 more source

Heart transplantation outcomes with donation after circulatory death in patients with left ventricular assist device

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Donation after circulatory death (DCD) has emerged as a strategy to increase the donor pool for heart transplantation (HT). Left ventricular assist device (LVAD) patients represent a discrete and unique population. We sought to explore the early outcomes of DCD‐HT compared with donation after brain death (DBD) HT in LVAD patients. Methods
Aris Karatasakis   +13 more
wiley   +1 more source

Angiotensin receptor‐neprilysin inhibitors in concurrent heart failure with reduced ejection fraction and kidney failure

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Angiotensin receptor‐neprilysin inhibitor (ARNI) therapy has demonstrated improved outcomes in heart failure with reduced ejection fraction (HFrEF). However, its benefits in patients with concomitant kidney failure undergoing replacement therapy remain uncertain. Methods and results Using the National Health Insurance Service database, we
Mi‐Hyang Jung   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy